Effects of Costovertebral Mobilization on Posture and Lung Function
Effects of Costovertebral Mobilization on Kyphotic Posture and Lung Function in Non Smoker
This study is testing if a special back treatment can improve posture and lung function in non-smokers aged 20-40 compared to regular therapy alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 20 Years to 40 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Islamabad) |
| Trial ID | NCT06530056 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of Costovertebral Mobilization on thoracic kyphosis and lung function in non-smokers aged 20-40. It is a randomized control trial involving 44 participants, where one group will receive Costovertebral Mobilization combined with conventional therapy, while the other group will receive only conventional therapy. The study aims to analyze the effects on lung function and posture by measuring the Cobb angle and forced expiratory volume ratios. Data will be processed using SPSS 25 to determine the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates are non-smoking individuals aged 20-40 with a normal BMI and specific lung function and kyphosis criteria.
Not a fit: Patients with respiratory diseases, significant spinal deformities, or a history of rib injuries will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve lung function and posture in individuals with hyperkyphosis.
How similar studies have performed: While there is limited data on the specific approach of Costovertebral Mobilization for this condition, similar manual therapy techniques have shown promise in improving posture and lung function.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Non smoker * Age: 20-40 years * Normal Body Mass Index 18.5 To 24.9 * Both female and male gender * Decrease forced expiratory volume-one second/ forced vital capacity ratio greater than or equal to 70% * Increase Thoracic kyphotic posture greater than or equal to 40˚ Exclusion Criteria: * Any respiratory disease of the upper or lower respiratory tracts e.g. asthma, chronic bronchitis, COPD, emphysema etc. which could altered the optimal lung functioning. * Previous history of rib fractures, dislocations, sprains of costochondral, costosternal and interchondral joints. * Smokers * Scheuermann Disease * Primary and Secondary neoplastic lesions of the spine and/or ribs * Obvious advanced spinal deformity e.g. kyphoscoliosis * Infection e.g. tuberculosis * Primary and secondary neoplastic lesions of the soft tissue structures of the chest * Inflammation e.g. acute rheumatoid arthritis or ankylosing spondylitis
Where this trial is running
Islamabad
- Madiha Ali — Islamabad, Pakistan (Recruiting)
Study contacts
- Principal investigator: Madiha Ali, MSOMPT — Riphah International University
- Study coordinator: Madiha Ali, MSOMPT
- Email: madiha.ali@riphah.edu.pk
- Phone: 0331-3360064
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.